Markets · Global Equities · US

Acumen Pharmaceuticals, Inc. ABOS

Exchange Nasdaq. Sector Pharma & biotech. Source: SEC companyfacts. Not a price feed.

• Revenue TTM —
• EBITDA TTM -105.97M
• Net debt -52.33M
• ND/EBITDA 0.49
• EBITDA/interest -25.1
• ROE -3.04
• Implied band BB

All countries